首页|A pilot study of precision treatment for patients with lung cancer pain by Longteng Tongluo recipe(龙藤通络方)using serum genomics

A pilot study of precision treatment for patients with lung cancer pain by Longteng Tongluo recipe(龙藤通络方)using serum genomics

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
A pilot study of precision treatment for patients with lung cancer pain by Longteng Tongluo recipe(龙藤通络方)using serum genomics
OBJECTIVE:To investigate the efficacy of Longteng Tongluo recipe(龙藤通络方,LTTL)combined with three-step analgesia for the treatment of lung cancer pain,and the changes in serum miRNA expressions before-and after treatment with LTTL and its correlation with lung cancer pain.The possible mechanism underlying LTTL effects on the treatment of lung cancer pain was conducted.METHODS:The pilot study was conducted at the oncology ward of the Yueyang Hospital and the Longhua Hospital between March 2018 and October 2019.A prospective,single-blind,placebo controlled,randomized clinical trial of LTTL or placebo combined with three-step analgesia treatments were administered to 24 cancer pain patients diagnosed with lung cancer.Analgesic efficacy was investigated as the primary outcome.Equivalent morphine consumption and numerical rating scale(NRS)scores were used as the secondary outcome.In the present study,we utilized deep sequencing techniques to compare the differential miRNA expressions in serum samples obtained from two groups:the lung cancer pain treatment group(LTTL+three-step analgesia)and the control group(placebo+three-step analgesia).Next,we employed the target prediction database to investigate the target genes for differential miRNA expressions and Gene Ontology(GO)analysis along with Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis to examine the roles and the major biochemical and signaling pathways related to the differentially expressed target genes,respectively.RESULTS:LTTL treatment significantly reduces the NRS score(P=0.021)as compared to those before treatment,along with significant reductions in the total morphine equivalent consumption(P=0.007)and the average daily equivalent morphine consumption(P=0.003)as opposed to the control group.The expressions of 31 miRNAs differed considerably between the two groups of patients(≥ 2 times up-modulated or down-regulated between these groups,P＜0.05).For instance,the miRNAs expression levels for patients before treatment(has-miR-2110 and has-miR-7d-3p)were significantly enhanced as compared to the healthy people,after LTTL treatment,the expressions of miR-2110 and miR-7d-3p in patients with lung cancer pain reduced significantly.Studies show that the above two miRNAs were significantly associated with lung cancer pain,which could mediate lung cancer pain.Furthermore,we identified 355 genes as potential targets of the 31 differentially expressed miRNAs.Pathway enrichment analyses using KEGG and GO analysis indicated that these target genes may play a crucial role in the development and modulation of lung cancer pain.CONCLUSION:LTTL demonstrated a discernible impact on alleviating lung cancer pain and its mechanism of action may be related to the downregulation of has-miR-2110 and has-miR-7d-3p expressions.This pilot study provides support for further exploration of LTTL in patients with lung cancer pain.

lung neoplasmspainneoplasm metastasishigh-throughput nucleotide sequencingLongteng Tongluo recipeMicroRNA-chip Supporting information

WU Ruixin、FANG Qingliang、GUAN Sisi、WEI Xianglong、SHAN Mengjun、MAO Zhujun、GONG Yabin、XU Ling、ZHOU Di、DONG Changsheng

展开 >

Preclinical Department,Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200071,China

School of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China

Department of Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China

Department of Oncology,the Third Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450003,China

Department of Oncology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China

Cancer Institute of Traditional Chinese Medicine/Department of Oncology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai,200032,China

展开 >

lung neoplasms pain neoplasm metastasis high-throughput nucleotide sequencing Longteng Tongluo recipe MicroRNA-chip Supporting information

2024

10.19852/j.cnki.jtcm.20240828.005

中医杂志(英文版)
中国中医药学会 中国中医研究院

中医杂志(英文版)

影响因子：0.855
ISSN：0255-2922
年,卷(期)：2024.44(5)